Tan et al. [12] elucidate immunohistochemical findings of the 54 patients with IMT, that the positive rate of makers ALK, SMA and Vim were 44.4%, 88.9% and 87.0%. This evidence concerns the gene SMN1 and inflammatory myofibroblastic tumor.